GAS5 and gastric cancer: These findings suggest that the down-regulation of lncRNA GAS5 expression in stomach cancer may reduce the YBX1 protein level by accelerating YBX1 protein turnover and that the low YBX1 abundance can decrease p21 expression, thus abolishing the G1 phase arrest.